RN7SL215P

Across TCGA pan-cancer cohorts, RN7SL215P RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated RN7SL215P data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RN7SL215P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RN7SL215P expression acts as an unfavorable survival marker.

OV, READ, and BRCA are the cancer types where RN7SL215P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	DFS	Tertile	All	0.233	0.389	.007	54	view →
READ	DFS	Tertile	III,IV	0.027	0.761	<.001	45	view →
BRCA	DFS	Tertile	IV	0.175	0.730	.005	42	view →
STAD	OS	Tertile	IV	0.052	0.541	.003	39	view →
GBM	DFS	Tertile	All	0.075	0.263	<.001	36	view →
THCA	DFS	Tertile	IV	0.205	0.872	<.001	36	view →
LGG	DFS	Tertile	All	0.361	0.762	.001	27	view →
BLCA	DFS	Tertile	IV	0.193	0.488	.008	18	view →
LIHC	DFS	Tertile	All	0.087	0.535	<.001	18	view →
SARC	OS	Tertile	All	0.176	0.522	.011	12	view →
THYM	OS	Tertile	II,III,IV	0.544	0.858	.038	3	view →
KIRP	DFS	Tertile	All	0.755	0.921	.043	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

RN7SL215P–OV (DFS)

Open the OV breakdown →